Catherine is a PhD and MBA-prepared leader with over a decade of experience leading large-scale health research operations. In 2019, she was named one of the 100 Best & Brightest Executive MBAs globally by Poets & Quants.
Why RetiSpec?
Working at RetiSpec inspires me everyday -- we are working together to revolutionize the diagnosis of Alzheimer's disease and other complex neurodegenerative diseases. When I speak with the many patients, caregivers, and clinicians who live with this devastating disease each day, I am so driven to bring our technology to the clinic in the most robust and rigorous way possible.

• 

  Chief Business Officer in RetiSpec

  Point of care and AI-driven early detection of Alzheimer’s, through a simple eye exam.